977 related articles for article (PubMed ID: 18310361)
21. AGG interspersion analysis of the FMR1 CGG repeats in mental retardation of unspecific cause.
Poon PM; Chen QL; Zhong N; Lam ST; Lai KY; Wong CK; Pang CP
Clin Biochem; 2006 Mar; 39(3):244-8. PubMed ID: 16337617
[TBL] [Abstract][Full Text] [Related]
22. The number of CGG repeats of the FMR1 locus in premutated and fully mutated heterozygotes and their offspring: implications for the origin of mosaicism.
Mingroni-Netto RC; Haddad LA; Vianna-Morgante AM
Am J Med Genet; 1996 Aug; 64(2):270-3. PubMed ID: 8844063
[TBL] [Abstract][Full Text] [Related]
23. Fragile X-associated tremor/ataxia syndrome: intrafamilial variability and the size of the FMR1 premutation CGG repeat.
Capelli LP; Gonçalves MR; Kok F; Leite CC; Nitrini R; Barbosa ER; Vianna-Morgante AM
Mov Disord; 2007 Apr; 22(6):866-70. PubMed ID: 17290448
[TBL] [Abstract][Full Text] [Related]
24. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.
Toledano-Alhadef H; Basel-Vanagaite L; Magal N; Davidov B; Ehrlich S; Drasinover V; Taub E; Halpern GJ; Ginott N; Shohat M
Am J Hum Genet; 2001 Aug; 69(2):351-60. PubMed ID: 11443541
[TBL] [Abstract][Full Text] [Related]
25. Screening for fragile X syndrome.
Murray J; Cuckle H; Taylor G; Hewison J
Health Technol Assess; 1997; 1(4):i-iv, 1-71. PubMed ID: 9414543
[TBL] [Abstract][Full Text] [Related]
26. Indicators of anxiety and depression in women with the fragile X premutation: assessment of a clinical sample.
Lachiewicz A; Dawson D; Spiridigliozzi G; Cuccaro M; Lachiewicz M; McConkie-Rosell A
J Intellect Disabil Res; 2010 Jul; 54(7):597-610. PubMed ID: 20629912
[TBL] [Abstract][Full Text] [Related]
27. [Abnormal function of ovaries in women carriers of premutation in the FMR1 gene].
Lisik MZ
Wiad Lek; 2007; 60(5-6):265-9. PubMed ID: 17966892
[TBL] [Abstract][Full Text] [Related]
28. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles.
Nolin SL; Brown WT; Glicksman A; Houck GE; Gargano AD; Sullivan A; Biancalana V; Bröndum-Nielsen K; Hjalgrim H; Holinski-Feder E; Kooy F; Longshore J; Macpherson J; Mandel JL; Matthijs G; Rousseau F; Steinbach P; Väisänen ML; von Koskull H; Sherman SL
Am J Hum Genet; 2003 Feb; 72(2):454-64. PubMed ID: 12529854
[TBL] [Abstract][Full Text] [Related]
29. Expansion to full mutation of a FMR1 intermediate allele over two generations.
Terracciano A; Pomponi MG; Marino GM; Chiurazzi P; Rinaldi MM; Dobosz M; Neri G
Eur J Hum Genet; 2004 Apr; 12(4):333-6. PubMed ID: 14735162
[TBL] [Abstract][Full Text] [Related]
30. Identification of small FRAXA premutations.
Francis D; Burgess T; Mitchell J; Slater H
Mol Diagn; 2000 Sep; 5(3):221-5. PubMed ID: 11070156
[TBL] [Abstract][Full Text] [Related]
31. The effect of CGG repeat number on ovarian response among fragile X premutation carriers undergoing preimplantation genetic diagnosis.
Bibi G; Malcov M; Yuval Y; Reches A; Ben-Yosef D; Almog B; Amit A; Azem F
Fertil Steril; 2010 Aug; 94(3):869-74. PubMed ID: 19481741
[TBL] [Abstract][Full Text] [Related]
32. Segregation of the fragile X mutation from a male with a full mutation: unusual somatic instability in the FMR-1 locus.
Kambouris M; Snow K; Thibodeau S; Bluhm D; Green M; Feldman GL
Am J Med Genet; 1996 Aug; 64(2):404-7. PubMed ID: 8844092
[TBL] [Abstract][Full Text] [Related]
33. Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene.
Schufreider A; McQueen DB; Lee SM; Allon R; Uhler ML; Davie J; Feinberg EC
Hum Reprod; 2015 Nov; 30(11):2686-92. PubMed ID: 26345686
[TBL] [Abstract][Full Text] [Related]
34. A new approach to antenatal screening for Fragile X syndrome.
Wald NJ; Morris JK
Prenat Diagn; 2003 Apr; 23(4):345-51. PubMed ID: 12673644
[TBL] [Abstract][Full Text] [Related]
35. Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests.
Berkenstadt M; Ries-Levavi L; Cuckle H; Peleg L; Barkai G
Prenat Diagn; 2007 Nov; 27(11):991-4. PubMed ID: 17705235
[TBL] [Abstract][Full Text] [Related]
36. Prenatal diagnosis and carrier screening for fragile X by PCR.
Brown WT; Nolin S; Houck G; Ding X; Glicksman A; Li SY; Stark-Houck S; Brophy P; Duncan C; Dobkin C; Jenkins E
Am J Med Genet; 1996 Jul; 64(1):191-5. PubMed ID: 8826474
[TBL] [Abstract][Full Text] [Related]
37. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
Mandel JL; Biancalana V
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
[TBL] [Abstract][Full Text] [Related]
38. An assessment of screening strategies for fragile X syndrome in the UK.
Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
[TBL] [Abstract][Full Text] [Related]
39. The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families.
Geva E; Yaron Y; Shomrat R; Ben-Yehuda A; Zabari S; Peretz H; Naiman T; Yeger H; Orr-Urtreger A
Genet Test; 2000; 4(3):289-92. PubMed ID: 11142761
[TBL] [Abstract][Full Text] [Related]
40. [Diagnostic testing in fragile X syndrome].
Sireteanu A; Rusu C
Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):968-71. PubMed ID: 17438909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
